Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, July 27, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
John Sourbeer Maintained (ABT) at Strong Buy with Decreased Target to $128 on, Jul 27th, 2022
John Sourbeer of UBS, Maintained "Abbott Laboratories" (ABT) at Strong Buy with Decreased Target from $142 to $128 on, Jul 27th, 2022.
John has made no other calls on ABT in the last 4 months.
There are 15 other peers that have a rating on ABT. Out of the 15 peers that are also analyzing ABT, 1 agrees with John's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Danielle Antalffy of "SVB Leerink" Maintained at Hold and Held Target at $140 on, Thursday, April 21st, 2022
These are the ratings of the 14 analyists that currently disagree with John
- Amit Hazan of "Goldman Sachs" Maintained at Strong Sell with Decreased Target to $104 on, Monday, July 25th, 2022
- Robbie Marcus of "JP Morgan" Maintained at Buy and Held Target at $125 on, Friday, July 22nd, 2022
- Shagun Singh of "RBC Capital" Maintained at Buy with Decreased Target to $132 on, Thursday, July 21st, 2022
- Cecilia Furlong of "Morgan Stanley" Maintained at Buy with Decreased Target to $132 on, Thursday, July 21st, 2022
- Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Decreased Target to $123 on, Thursday, July 21st, 2022
- Vijay Kumar of "Evercore ISI Group" Maintained at Buy with Decreased Target to $112 on, Wednesday, July 20th, 2022
- Ryan Zimmerman of "BTIG" Maintained at Strong Buy with Decreased Target to $126 on, Monday, July 18th, 2022
- Rick Wise of "Stifel" Maintained at Strong Buy with Decreased Target to $126 on, Monday, July 18th, 2022
- Jayson Bedford of "Raymond James" Maintained at Buy with Decreased Target to $117 on, Friday, July 15th, 2022
- Joshua Jennings of "TD Cowen" Maintained at Buy with Decreased Target to $130 on, Wednesday, July 13th, 2022
- Mike Polark of "Wolfe Research" Initiated at Sell on, Wednesday, July 6th, 2022
- Marie Thibault of "BTIG" Maintained at Strong Buy with Decreased Target to $130 on, Friday, June 24th, 2022
- Travis Steed of "B of A Securities" Maintained at Strong Buy and Held Target at $140 on, Tuesday, May 31st, 2022
- Larry Biegelsen of "Wells Fargo" Maintained at Buy with Decreased Target to $150 on, Friday, April 8th, 2022
